|9.95|| +0.06 / +0.61%|
OPKO Health, Inc. is a multi-national pharmaceutical and diagnostics company. The company is engaged in discovering, developing, commercializing and expertise its novel and proprietary technologies with a focus to provide unmet medical needs through a range of develops solutions to diagnose, treat and prevent various conditions, including molecular diagnostics, point-of-care tests and proprietary pharmaceuticals and vaccines. It operates its business through two segments: Pharmaceutical and Diagnostics. The Pharmaceutical segment consists of pharmaceutical research and development operations in Chile, Mexico, Ireland, Israel and Spain. The Diagnostics segment consists of pathology operations and point-of-care and molecular diagnostics operations. OPKO Health was founded in October 1991 and is headquartered in Miami, FL.
|Phillip Frost||Chairman & Chief Executive Officer|
|Adam E. Logal||Chief Financial Officer, Treasurer, CAO & SVP|
|Jane H. Hsiao||Vice Chairman & Chief Technology Officer|
|Stephen A. Strugnell||Senior Director-Scientific Affairs|
|Douglass H. Laidlaw||Vice President-Medical Affairs|